Quest Diagnostics' consistent ROCE and increased capital employed over the past five years suggest steady reinvestment at good returns. This trend, reflected in the stock's strong performance, is expected to continue.
The acquisition aligns with Quest's strategy to grow through accretive outreach laboratory acquisitions and expands its ability to serve providers and patients in Ohio and Pennsylvania.
The CEO of Quest Diagnostics, Jim Davis, believes Yuri Fesko's deep medical expertise and patient-care advocacy will greatly contribute to the company's strategic decisions. His appointment especially bolsters Quest's efforts to improve customer experiences via diagnostic innovations.
Quest Diagnostics shows favorable metrics with robust reinvestment strategies. Significant earnings growth and an anticipated rise in future ROE, despite a higher payout ratio, hint at other growth factors.
Since he will be retiring, I wanted to highlight his unusual trading while in Congress for 40 years. He became a millionaire many times over on a modest federal salary from trading. Take a look: Thomas Carper bought 30k in$做空納斯達克100指數ETF-ProShares(PSQ.US)$, an ultrashort$納指100ETF-Invesco QQQ Trust(QQQ.US)$index, on July 13 2023. He hedged/shorted in the past with great results with$AdvisorShares主動股票做空ETF(HDGE.US)$, ...
The Covid-19 pandemic isn’t over but the U.S. is already entering a new vaccine boom. But the delayed vaccine rollout continues to raise questions. CNN reports that the U.S. delayed a large-scale vaccine order out of fear of the shots expiring before being administered. Federal agencies are exploring new ways to provide vaccines more efficiently, but the supply shortage poses challenges. For the U.S. government,...
奎斯特診療股票討論區
Senator Thomas Carper disclosed he profited shorting the US economy.
He became a millionaire many times over on a modest federal salary from trading.
Take a look:
Thomas Carper bought 30k in $做空納斯達克100指數ETF-ProShares(PSQ.US)$ , an ultrashort $納指100ETF-Invesco QQQ Trust(QQQ.US)$ index, on July 13 2023.
He hedged/shorted in the past with great results with $AdvisorShares主動股票做空ETF(HDGE.US)$ , ...
2023Q1營收繼續下滑10.7%,營業利潤大幅下滑40.6%,淨利潤大幅下滑41.8%。
目前市盈率17.6,市盈率TTM已經提升到20.6,考慮到近期利潤大幅萎縮,暫時缺乏吸引力。
The White House is about to turn to vaccine producers to curb the spread of monkeypox
專欄Today's pre-market stock movers: TSLA, T, NOK, UAL and more
In reaction to earnings/guidance:
• $超微電腦(SMCI.US)$ +18%,$諾基亞(NOK.US)$ +7.7%,$丹納赫(DHR.US)$ +6.3%,$RLI保險(RLI.US)$ +5%,$CSX運輸(CSX.US)$ +4.3%,$金沙集團(LVS.US)$ +4.2%,$美國鋁業公司(AA.US)$ +3.4%(also authorizes new $500 mln share repurchase program)
• $Steel Dynamics(STLD.US)$ +2.8%,$Herc Holdings(HRI.US)$ +2.6%,$特斯拉(TSLA.US)$ +2.5%, $菲利普莫里斯(PM.US)$ +2.5%,$F.N.B. Corp(FNB.US)$ ...
專欄Today's pre-market stock movers: TWTR, NIU, OCGN, SBUX and more
• $Twitter (Delisted)(TWTR.US)$ +20.5% (Elon Musk discloses 9.2% passive stake)
• $康特科技(CAMT.US)$ +9.6%, $Perion Network(PERI.US)$ +6.6% (In reaction to earnings/guidance)
• $小牛電動(NIU.US)$ +5% (reports QI sales volume increased 9.4% yr/yr)
• $Iron Spark I Inc(ISAA.US)$ +3.4% (Hypebeast plans to list on NASDAQ through Merger with Iron Spark I)
• $Gatos Silver(GATO.US)$ +2.3% (Provides Bi-Weekly Status Report)
• $Verve Therapeutics(VERV.US)$ +1.8% (re...
專欄Top upgrades and downgrades on 4/4
• $DCP Midstream(DCP.US)$ : Evercore ISI Upgrades to Outperform from In Line - PT $42 (from $36)
• $Leslie's(LESL.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $27 (from $26)
• $羅技(LOGI.US)$ : Goldman Sachs Upgrades to Buy from Neutral
• $蔚來(NIO.US)$ : UBS Upgrades to Buy from Neutral - PT $32 (from $46)
• $Ollie's Bargain Outlet(OLLI.US)$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $65 (from $45)
• $Oric Pharmaceuticals(ORIC.US)$ : Citigro...
暫無評論